Adverse Drug Reactions: The Great Masqueraders

  • 3 Citations

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 189

This is the net price. Taxes to be calculated in checkout.


  1. 1.

    Vere, DW. Drug adverse reactions as masquereders. Adverse Drug Reaction Bull. 1976;60:208–211.

  2. 2.

    Ahmed, M, Davison, OW. Severe cystitis associated with tiaprofenic acid. Br Med, J. 1991;303:1376.

  3. 3.

    Ghose, K. Cystitis and nonsteroidal antiinflammatory drugs: an incidental association or an adverse effect? New Zealand Med, J. 1993;106:501–503.

  4. 4.

    Greene, GF, Millard, OH, Norman, RW, Boudreau, SF, Auld, RB, Awad, SA. Cystitis associated with tiaprofenic acid. J Urol. 1994;152:1101–1102.

  5. 5.

    Harrison, WJ, Willis, RG, Neal, DE. Adverse reactions to tiaprofenic acid mimicking interstitial cystitis. Br Med, J. 1994;309:574.

  6. 6.

    O’Neil, GF. Tiaprofenic acid as a cause of non-bacterial cystitis. Med J Australia. 1994;160:123–125.

  7. 7.

    Anon. Severe cystitis with tiaprofenic acid (Surgam). Current Prob. 1994;21:11.

  8. 8.

    Terol, MJ, Cervantes, F, Pereira, A, Rozman, C. Autoimmune hemolytic anaemia after 9 years of treatment with alphmethyldopa. (letter). Med Clin Bare. 1991:101:598.

  9. 9.

    McKenzie, R, Fried, MW, Sallie, R, Conjeevaram, H, Di-Bisceglie, AM, Park, Y, Savarese, B, Kleiner, D, Tsokos, M, Luciano, C, et al. Hepatic failure and lactic acidosis due to fialuridine (FLAU), an investigational nucleoside analogue for chronic hepatitis, B. N Engl J Med. 1995;333(17):1099–1105.

  10. 10.

    Pepys, J, Pepys, EO, Baldo, BA, Whitwam, JG. Anaphylactic/anaphylactoid reactions to anaesthetic and associated agents. Skin prick tests in aetiological diagnosis. Anaesthetic. 1994;49:470–475.

  11. 11.

    Stephens, M. Deliberate drug rechallenge. Hum Toxicol. 1983;2(4):573–577.

  12. 12.

    Smith, PM, Wilton, A, Routledge, PA. Case report. Jaundice associated with amoxycillin—clavulonate potassium therapy. Eur J Gastroenterol Hepatol. 1991;3:95–96.

  13. 13.

    Miros, M, Kerlin, P, Walker, N, Harris, O. Flucloxacillin induced delayed cholestatic hepatitis. Aust New Zealand J Med. 1990;20:251–253.

  14. 14.

    Davies, MH, Harrison, RF, Elias, E, Hubscher, SG. Antibiotic-associated acute vanishing bile duct syndrome; a pattern associated with severe, prolonged, intrahepatic cholestasis. J Hepatol. 1994;20:112–116.

  15. 15.

    Rawlins, MD. Pharmacovigilance: paradise lost, regained or postponed? J Roy Coll Physicians. 1995; 29:41–49.

  16. 16.

    Bateman, DN, Sanders GLS, Rawlins, MD. Attitudes to adverse drug reaction reporting: The Northern Region. Br J Clin Pharmac. 1992;34:421–426.

  17. 17.

    Houghton, JE, Pinto Pereira, LM, Woods, FJ, Richens, A, Routledge, PA. The Welsh Adverse Drug Reactions Scheme; experience of a UK regional monitoring centre. Adverse Drug Reac Toxicol Rev. 1996; 15(2).

  18. 18.

    Albengres, E, Gauthier, F, Tillement, JP. Current French system of post-marketing drug surveillance. Int J Clin Pharmacol Ther Toxicol. 1990;312–314.

  19. 19.

    Begaud, B, Chaslerie, A, Haramburu, F. Organization and results of drug vigilance in France. Rev Epidemiol Sante Publique. 1994;42:416–423.

  20. 20.

    Edwards, IR, Lindquist, M, Wiholm, BE, Napke, E. Quality criteria for early signals of possible adverse drug reactions. Lancet. 1990;336:156–158.

  21. 21.

    Griffin, JP. Survey of the adverse drug reporting ode-mas in fifteen countries. Br J Clin Pharmacol. 1986; 22:835–1005.

  22. 22.

    Walker, RS, Linton, AL. Phenethyldiguanide: A dangerous side-effect. Br Med, J. 1959;2:1005–1006.

  23. 23.

    Chandalia, HB, Rangnath, M. Biguanide induced lactic acidosis. J Ass Physicians India. 1990;38:620–622.

  24. 24.

    McGuinness, ME, Talbert, RJ. Phenformin-induced lactic acidosis: a forgotten adverse drug reaction. Ann Pharmacother. 1993;27:1183–1187.

  25. 25.

    Soria-Royer, C, Legendre, C, Mircheva, J, Premel, S, Beaune, P, Kreis, H. Thiopurine-methyl transferase activity to assess azathioprine myeltoxicity in renal transplant recipients (letter). Lancet. 1993;341(8860) 1593–1594.

  26. 26.

    Evans DAP, Manley, KA, Makusick, VA. Genetic control of isoniazid metabolism in man. Br Med, J. 1960;2:485–491.

  27. 27.

    Adams, LE, Hess, EV. Drug-related lupus. Incidence, mechanisms and clinical implications. Drug Safety. 1991:6:431–449.

  28. 28.

    Hutchings, A, Routledge, PA. A simple method for determining acetylator phenotype using isoniazid. Br J Clin Pharmac. 1986;22:343–345.

  29. 29.

    Hutchings, A, Routledge, PA. A single sample sauva test to measure acetylator phenotype using isoniazid. Br J Clin Pharmac. 1996;42:635–637.

  30. 30.

    Bechtel, PR. Relevance and limits of pharmacogenetics to detect patients at risk of adverse drug reactions. Pharmacoepidem Drug Safety. 1995;4:31–36.

Download references

Author information

Correspondence to Professor P. A. Routledge.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Routledge, P.A., Bialas, M.C., Houghton, J.E. et al. Adverse Drug Reactions: The Great Masqueraders. Ther Innov Regul Sci 32, 79–84 (1998).

Download citation